Evidence map›Paper›PMID 38412432›Full record

ArticleJournal of natural products2024

Biochemical and Structural Studies of the Carminomycin 4-

Elnaz Jalali, Fengbin Wang, Brooke R Overbay, Mitchell D Miller, Khaled A Shaaban, Larissa V Ponomareva, Qing Ye, Hoda Saghaeiannejad-Esfahani, Minakshi Bhardwaj, Andrew D Steele and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of natural products, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Elnaz Jalali
Fengbin WangDepartment of Biosciences, Rice University, Houston, Texas 77030, United States.
Brooke R Overbay
Mitchell D MillerDepartment of Biosciences, Rice University, Houston, Texas 77030, United States.
Khaled A ShaabanORCID 0000-0001-7638-4942
Larissa V Ponomareva
Qing YeMarkey Cancer Center, Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, Kentucky 40536, United States.
Hoda Saghaeiannejad-Esfahani
Minakshi Bhardwaj
Andrew D SteeleORCID 0000-0002-1252-1992
Christiana N Teijaro
Ben ShenORCID 0000-0002-9750-5982
Steven G Van LanenORCID 0000-0003-1539-2732
Qing-Bai SheMarkey Cancer Center, Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, Kentucky 40536, United States.
S Randal VossDepartment of Neuroscience, University of Kentucky, Lexington, Kentucky 40536, United States.
George N PhillipsDepartment of Biosciences, Rice University, Houston, Texas 77030, United States.
Jon S ThorsonORCID 0000-0002-7148-0721

Funding

User Training & OutreachP30GM138396 · NIGMS · UCHICAGO ARGONNE, LLC · PI JANET L. SMITH · 2020 to 2026
$34.3M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular diseaseP20GM130456 · NIGMS · UNIVERSITY OF KENTUCKY · PI Jon Scott Thorson · 2020 to 2026
$18.7M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Mining Actinomycetal Genomes for Natural Product Discovery and BiosynthesisR35GM134954 · NIGMS · UNIVERSITY OF FLORIDA · PI Ben Shen · 2020 to 2026
$5.1M
In Vitro Glycorandomization of Natural ProductsR37AI052218 · NIAID · UNIVERSITY OF KENTUCKY · PI THORSON, JON SCOTT · 2012 to 2021
$4.0M
Targeting Translation Dependence in Colorectal Cancer ProgressionR01CA175105 · NCI · UNIVERSITY OF KENTUCKY · PI SHE, QING-BAI · 2013 to 2024
$3.3M
Natural product-based modulators of 4E-BP1 phosphorylationR01CA203257 · NCI · UNIVERSITY OF KENTUCKY · PI SHE, QING-BAI, THORSON, JON SCOTT · 2016 to 2020
$1.9M
Bruker AVANCE NEO 600 MHz High-Performance Digital NMR SpectrometerS10OD028690 · OD · UNIVERSITY OF KENTUCKY · PI GARNEAU-TSODIKOVA, SYLVIE · 2020 to 2020
$1.4M
Translational Control in Cr(VI) CarcinogenesisR21ES031712 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHE, QING-BAI · 2020 to 2021
$421k
Biosynthesis of the Leinamycin Family of Natural Products: Mechanistic Studies and Chemoenzymatic Analog SynthesisF32GM133114 · NIGMS · UNIVERSITY OF FLORIDA · PI STEELE, ANDREW · 2019 to 2021
$195k
Novel Tiancimycins (TNMs) Antibody Drug Conjugates (ADCs) for Anticancer TherapeuticsF32GM128345 · NIGMS · SCRIPPS FLORIDA · PI TEIJARO, CHRISTIANA NICOLE · 2019 to 2021
$155k
NCATS NIH HHS UL1 TR000117NCATS NIH HHS UL1 TR001998NCI NIH HHS R01 CA175105NCI NIH HHS R01 CA203257NIAID NIH HHS R37 AI052218NIEHS NIH HHS R21 ES031712NIGMS NIH HHS F32 GM128345NIGMS NIH HHS F32 GM133114NIGMS NIH HHS P20 GM130456NIGMS NIH HHS P30 GM138396NIGMS NIH HHS R35 GM134954NIH HHS S10 OD028690
6 · The paper itself

Abstract

Structural and functional studies of the carminomycin 4-

Indexed as

MethyltransferasesAnthracyclinesBiological ProductsHumansMolecular StructureSubstrate SpecificityAnthracyclinesBiological ProductsMethyltransferases

Identifiers

PMID38412432
PMCPMC11623920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.